The medical device company Alere Inc. will pay the United States $33.2 million to resolve allegations brought against it under the federal False Claims Act. The complaint alleged that Alere knowingly submitted false claims to federal and state healthcare programs for unreliable point-of-care diagnostic testing devices, according to a U.S. Justice Department press release.
The Centers for Medicare and Medicaid Services (CMS) has issued the Health and Human Services Notice of Benefits and Payment Parameters for 2019. “The final rule will mitigate the harmful impacts of Obamacare and empower states to regulate their insurance market,” CMS said in a statement.
McKesson Corp., one of the nation’s largest pharmaceutical companies, and two of its subsidiaries have had federal and state False Claims Act allegations filed against them on behalf of the federal government, 30 state governments, and the city governments of Chicago, New York City, and the District of Columbia.